Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA1813 BulevirtideSummary: Bulevirtide (MyrcludexB) is an inhibitor and is a linear lipopeptide. -
BA1814 SelgantolimodSummary: Selgantolimod (GS-9688) is orally active. -
BA1815 RG7834Summary: RG7834 (RO7020322) is a highly selective, orally available inhibitor. -
BA1816 EntecavirSummary: Entecavir (SQ34676;BMS200475) is a selective and potent inhibitor. -
BA1817 MorphothiadinSummary: Morphothiadin is a potent inhibitor of wild-type and adefovir-resistant replication. -
BA1818 BicyclolSummary: Bicyclol (SY801) is an orally available anti-HBV. -
BA1819 VebicorvirSummary: Vebicorvir (ABI-H0731) is a generational inhibitor of the hepatitis B virus (HBV) core protein. -
BA1820 BersacapavirSummary: A novel regulator of hepatitis B virus capsid assembly>. -
BA1821 BepirovirsenSummary: Bepirovirsen is an antisense oligonucleotide that targets all messenger RNAs. -
BA1822 AzvudineSummary: Azvudine (RO-0622) is a potent nucleoside reverse transcriptase inhibitor with antiviral activity.

